Literature DB >> 25527177

Cardiac purinergic signalling in health and disease.

Geoffrey Burnstock1, Amir Pelleg.   

Abstract

This review is a historical account about purinergic signalling in the heart, for readers to see how ideas and understanding have changed as new experimental results were published. Initially, the focus is on the nervous control of the heart by ATP as a cotransmitter in sympathetic, parasympathetic, and sensory nerves, as well as in intracardiac neurons. Control of the heart by centers in the brain and vagal cardiovascular reflexes involving purines are also discussed. The actions of adenine nucleotides and nucleosides on cardiomyocytes, atrioventricular and sinoatrial nodes, cardiac fibroblasts, and coronary blood vessels are described. Cardiac release and degradation of ATP are also described. Finally, the involvement of purinergic signalling and its therapeutic potential in cardiac pathophysiology is reviewed, including acute and chronic heart failure, ischemia, infarction, arrhythmias, cardiomyopathy, syncope, hypertrophy, coronary artery disease, angina, diabetic cardiomyopathy, as well as heart transplantation and coronary bypass grafts.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25527177      PMCID: PMC4336308          DOI: 10.1007/s11302-014-9436-1

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  764 in total

Review 1.  Ganglia within the gut, heart, urinary bladder, and airways: studies in tissue culture.

Authors:  M J Saffrey; C J Hassall; T G Allen; G Burnstock
Journal:  Int Rev Cytol       Date:  1992

2.  Adenosine-vagus interaction at the cellular level.

Authors:  T Mazgalev; L S Dreifus; E L Michelson; A Pelleg
Journal:  Prog Clin Biol Res       Date:  1987

3.  Intravascular ATP and coronary vasodilation in the isolated working rat heart.

Authors:  O Korchazhkina; G Wright; C Exley
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

4.  Activation of protein kinase B by adenosine A1 and A3 receptors in newborn rat cardiomyocytes.

Authors:  Renée Germack; Martin Griffin; John M Dickenson
Journal:  J Mol Cell Cardiol       Date:  2004-11       Impact factor: 5.000

5.  Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors.

Authors:  Johanna Balogh; Anna-Karin Wihlborg; Henrik Isackson; Bhalchandra V Joshi; Kenneth A Jacobson; Anders Arner; David Erlinge
Journal:  J Mol Cell Cardiol       Date:  2005-08       Impact factor: 5.000

6.  Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway.

Authors:  Olivier C Manintveld; Maaike te Lintel Hekkert; Elisabeth Keijzer; Pieter D Verdouw; Dirk J Duncker
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

Review 7.  Pharmacology and therapeutic applications of A1 adenosine receptor ligands.

Authors:  Arvinder K Dhalla; John C Shryock; Revati Shreeniwas; Luiz Belardinelli
Journal:  Curr Top Med Chem       Date:  2003       Impact factor: 3.295

8.  Increased expression of adenosine A2A receptors in patients with spontaneous and head-up-tilt-induced syncope.

Authors:  Louis Carrega; Alain Y Saadjian; Laurence Mercier; Ibrahim Zouher; Jean-Louis Bergé-Lefranc; Victoria Gerolami; Philippe Giaime; Pascal Sbragia; Franck Paganelli; Emmanuel Fenouillet; Samuel Lévy; Régis P Guieu
Journal:  Heart Rhythm       Date:  2007-03-12       Impact factor: 6.343

9.  Activation of purinergic receptors by ATP induces ventricular tachycardia by membrane depolarization and modifications of Ca2+ homeostasis.

Authors:  Iman S Gurung; Asli Kalin; Andrew A Grace; Christopher L-H Huang
Journal:  J Mol Cell Cardiol       Date:  2009-08-10       Impact factor: 5.000

10.  Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.

Authors:  Marieke L Fokkema; Pieter J Vlaar; Mathijs Vogelzang; Youlan L Gu; Marthe A Kampinga; Bart J de Smet; Gillian A Jessurun; Rutger L Anthonio; Ad F van den Heuvel; Eng-Shiong Tan; Felix Zijlstra
Journal:  Circ Cardiovasc Interv       Date:  2009-07-22       Impact factor: 6.546

View more
  36 in total

Review 1.  Extracellular ATP and other nucleotides-ubiquitous triggers of intercellular messenger release.

Authors:  Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2015-11-06       Impact factor: 3.765

2.  The effects of NONRATT021972 lncRNA siRNA on PC12 neuronal injury mediated by P2X7 receptor after exposure to oxygen-glucose deprivation.

Authors:  Guilin Li; Lifang Zou; Wei Xie; Shiyao Wen; Qiuyu Xie; Yun Gao; Changshui Xu; Hong Xu; Shuangmei Liu; Shouyu Wang; Yun Xue; Bing Wu; Qiulan Lv; Mofeng Ying; Xi Zhang; Shangdong Liang
Journal:  Purinergic Signal       Date:  2016-04-21       Impact factor: 3.765

Review 3.  Cell type- and tissue-specific functions of ecto-5'-nucleotidase (CD73).

Authors:  Marquet Minor; Karel P Alcedo; Rachel A Battaglia; Natasha T Snider
Journal:  Am J Physiol Cell Physiol       Date:  2019-08-28       Impact factor: 4.249

4.  Differential protection of black-seed oil on econucleotidase, cholinesterases and aminergic catabolizing enzyme in haloperidol-induced neuronal damage of male rats.

Authors:  Jacob K Akintunde; C Abigail Irechukwu
Journal:  Ther Adv Drug Saf       Date:  2016-07-22

Review 5.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 6.  Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.

Authors:  Zhichao Zhou; Takayuki Matsumoto; Vera Jankowski; John Pernow; S Jamal Mustafa; Dirk J Duncker; Daphne Merkus
Journal:  Pharmacol Res       Date:  2018-12-13       Impact factor: 7.658

7.  Coupling switch of P2Y-IP3 receptors mediates differential Ca(2+) signaling in human embryonic stem cells and derived cardiovascular progenitor cells.

Authors:  Jijun Huang; Min Zhang; Peng Zhang; He Liang; Kunfu Ouyang; Huang-Tian Yang
Journal:  Purinergic Signal       Date:  2016-04-20       Impact factor: 3.765

8.  Involvement of P2Y12 receptor of stellate ganglion in diabetic cardiovascular autonomic neuropathy.

Authors:  Jingjing Guo; Xuan Sheng; Yu Dan; Yurong Xu; Yuanruohan Zhang; Huihong Ji; Jiayue Wang; Zixi Xu; Hongyu Che; Guodong Li; Shangdong Liang; Guilin Li
Journal:  Purinergic Signal       Date:  2018-08-06       Impact factor: 3.765

Review 9.  Short- and long-term (trophic) purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-08-05       Impact factor: 6.237

Review 10.  Unlocking the Potential of Purinergic Signaling in Transplantation.

Authors:  R Zeiser; S C Robson; T Vaikunthanathan; M Dworak; G Burnstock
Journal:  Am J Transplant       Date:  2016-04-28       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.